Bill Maris is the founder of Section 32, a venture capital fund investing at the frontiers of technology and biology.  Bill has invested in over 500 companies, resulting in more than 30 IPOs, 100+ mergers and acquisitions and 50+ companies that have exceeded $1B valuations, including Aurora Innovation, Nest (acquired by Google), Uber (NASDAQ: UBER), Crowdstrike (NASDAQ: CRWD), Coinbase, 23andme, Flatiron Health (acquired by Roche), Foundation Medicine (acquired by Roche), The Climate Corporation (acquired by Monsanto), and Adimab.

Bill is the founder and first CEO of Google Ventures, where he was also Vice President of Special Projects. He worked closely with Google X, Waymo and Verily, and led global investment activities for Google and Alphabet. Bill is also the founder of Calico, a multi-billion dollar company focused on understanding aging and extending life.

Bill is the founder of one of the world’s first web-hosting companies, and prior to that he worked with Sweden’s Investor AB.

In the mid-2000s, he partnered with entrepreneur David Green to transfer a novel hydrophobic acrylic lens to Aurolab to treat and cure cataract blindness in the developing world. It has since helped prevent or cure cataract blindness in more than 40 million people worldwide.

Bill has a degree in neuroscience from Middlebury College, and his background includes research at the Duke University School of Medicine, Department of Neurobiology.